Ads
related to: pfizer, drugmaker
Search results
Better High-Yield Dividend Stock: Pfizer vs. Bristol Myers Squibb
Motley Fool via Yahoo Finance· 7 days agoAt present, the drugmaker sports 37 candidates in late-stage development, underscoring the strength...
UK Government Snubs GSK in Favor of Pfizer’s Rival RSV Shot
Bloomberg· 23 hours agoHave a confidential tip for our reporters? GSK Plc has lost out to Pfizer Inc. on a contract to...
Pfizer (PFE) Exceeds Market Returns: Some Facts to Consider
Zacks via Yahoo Finance· 7 days agoPfizer (PFE) closed at $27.41 in the latest trading session, marking a +1.59% move from the prior...
Alnylam Stock Pops on Surprising Results From a Key Heart Disease Drug
Barrons.com· 19 hours agoAlnylam said that patients with a rare heart condition called ATTR amyloidosis...The reduction was...
Pfizer Inc. (PFE) is Attracting Investor Attention: Here is What You Should Know
Zacks via Yahoo Finance· 4 days agoPfizer (PFE) has received quite a bit of attention from Zacks.com users lately. Therefore, it is...
Alnylam (ALNY) Stock Soars 30% on Heart Disease Drug Success
InvestorPlace· 20 hours agoHeart disease drugmaker Alnylam (NASDAQ:ALNY) stock rose sharply on the success of a Phase 3 study...
The Zacks Analyst Blog Highlights Pfizer, Johnson & Johnson and Eli Lilly
Zacks via Yahoo Finance· 4 days agoIts revenues have jumped from $28.3 billion in 2021 to $34.1 billion in 2023. Conclusion While other...
3 No-Brainer Stocks to Buy for Under $100 Right Now
Motley Fool via Yahoo Finance· 3 days agoManagement is looking for around $25 billion in additional annual revenue by 2030 from its business development deals. These acquisitions haven't...
Alnylam's drug cuts risk of death, heart issues in key study, shares jump
Reuters via Yahoo News· 23 hours ago(Reuters) -Alnylam Pharmaceuticals said its drug vutrisiran reduced deaths and cardiovascular events by a third in a study involving patients with a rare heart disease, sending the ...
Novavax Seeks FDA Nod for Updated COVID-19 Vaccine - Novavax (NASDAQ:NVAX), Moderna (NASDAQ:MRNA)
Benzinga· 7 days agoSubject to necessary permissions from the FDA and CDC, Novavax intends to market this updated...